We have recently reported the presence of the calcium sensing receptor (CaR) in keratinocytes and suggested that it signaled calcium-induced differentiation of these cells. cDNA clones encoding the full-length CaR were isolated from human keratinocytes. In addition, an alternatively spliced form that lacks exon 5, encoding a portion of the extracellular domain, also was found. (5), which block the rise of [Ca 2ϩ ] i , block the ability of [Ca 2ϩ ] o to induce differentiation. Inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerol levels increase rapidly after the calcium switch (4) as does transmembrane calcium influx presumably through nonspecific cation channels (6, 7) and the recently cloned cGMP-gated channels (8). These responses are reminiscent of those in the parathyroid gland (9) where parathyroid hormone secretion is tightly regulated by [Ca 2ϩ ] o . An extracellular calcium sensing receptor was identified in bovine parathyroid tissue (10), and subsequently a human homologue of the same receptor was cloned from human parathyroid glands (11). This receptor is a member of the superfamily of G-protein-coupled membrane receptors. Calcium binding results in G-protein-dependent stimulation of phospholipase C activity increasing IP 3 production, rapid release of [Ca 2ϩ ] i from intracellular stores, and activation of transmembrane calcium influx (reviewed in Refs. 12 and 13).
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above 0.1 mM (calcium switch) inhibits proliferation and induces the onset of terminal differentiation. One early response to the calcium switch is a rise in intracellular free Ca 2ϩ ([Ca 2ϩ ] i ) (reviewed in Ref. 4) . Pharmacological agents like the intracellular calcium chelator (5) , which block the rise of [Ca 2ϩ ] i , block the ability of [Ca 2ϩ ] o to induce differentiation. Inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerol levels increase rapidly after the calcium switch (4) as does transmembrane calcium influx presumably through nonspecific cation channels (6, 7) and the recently cloned cGMP-gated channels (8) . These responses are reminiscent of those in the parathyroid gland (9) where parathyroid hormone secretion is tightly regulated by [Ca 2ϩ ] o . An extracellular calcium sensing receptor was identified in bovine parathyroid tissue (10) , and subsequently a human homologue of the same receptor was cloned from human parathyroid glands (11) . This receptor is a member of the superfamily of G-protein-coupled membrane receptors. Calcium binding results in G-protein-dependent stimulation of phospholipase C activity increasing IP 3 production, rapid release of [Ca 2ϩ ] i from intracellular stores, and activation of transmembrane calcium influx (reviewed in Refs. 12 and 13) .
The observation that keratinocytes have intracellular responses to the change of [Ca 2ϩ ] o like parathyroid cells prompted us to seek the presence of a calcium receptor (CaR) in keratinocytes. This CaR might mediate the response of keratinocytes to [Ca 2ϩ ] o with respect to differentiation. We have reported a partial CaR cDNA (823 bp) derived from normal human keratinocytes (14) , the sequence of which was essentially identical to the sequence of the transmembrane domain of the human parathyroid CaR (11) . In the current study, we completed the sequencing of the keratinocyte CaR. In the process, we found an alternatively spliced form that lacks exon 5. This spliced variant is unable to mediate the acute response to [Ca 2ϩ ] o and has an altered glycosylation pattern. This variant reduced the IP response of the full-length CaR when they were coexpressed. The transcript of the full-length CaR was predominantly expressed in undifferentiated cells, and it decreased as the cells differentiated. Whereas the transcript of the spliced variant was expressed throughout differentiation. These molecular changes are consistent with the decrease of [Ca 2ϩ ] i and IP 3 response to [Ca 2ϩ ] o during differentiation.
EXPERIMENTAL PROCEDURES
Cell Culture-Normal human keratinocytes were isolated from newborn human foreskin by trypsinization (0.25% trypsin, 4°C, 16 h). Primary cultures of keratinocytes were prepared as described (15) . Briefly, cells were grown in serum-free keratinocyte growth medium (KGM, Clonetics) supplemented with 0.07 mM Ca 2ϩ for 2 days, then switched to the same medium containing 0.03, 0.1, or 1.2 mM Ca 2ϩ , and cultured for different times before harvest.
Measurement of [Ca 2ϩ ] i - [Ca 2ϩ ] i measurement in suspended keratinocytes was carried out as described previously (14) . Briefly, trypsinized keratinocytes cultured with various conditions were loaded with 2 M Indo-1 AM or 0.75 M Fura-2 AM in buffer A (20 mM Hepes buffer, pH 7.4, containing 120 mM sodium chloride, 5 mM potassium chloride, 1 mM magnesium chloride, 1 mg/ml pyruvate, 1 mg/ml glucose, and 0.03 mM calcium chloride). Cells were then washed and resuspended in buffer A at the cell density of 1-1.5 ϫ 10 6 cell/ml. Fluorescence was recorded with a fluorometer (650 -40; Perkin-Elmer) using 350 and 405 nm for excitation and emission wavelengths, respectively. Each sample was calibrated by the addition of ionomycin (10 M final concentration) (F max ) followed by 0.1% Triton X-100 and 10 mM EGTA/ Tris, pH 8.3 (F min ). [Ca 2ϩ ] i was calculated from the following formula: Calcium-stimulated IP production in HEK293 cell was measured as an index of calcium sensing activity of the transfected CaR. The IP production in transiently transfected cells was determined as described (17) . Transiently transfected cells were cultured in Dulbecco's modified Eagle's medium with 10% fetal calf serum and were radiolabeled by myo- [ 3 H]inositol (2 Ci/ml) for 24 h. The cells were washed with Hepesbuffered minimum Eagle's medium containing 0.5 mM CaCl 2 and 0.5 mM MgCl 2 and pretreated with 10 mM LiCl in the same medium for 15 min. The cells were then stimulated with different concentrations of calcium (5-40 mM CaCl 2 ) in the presence of 10 mM LiCl for 1 h. Unstimulated cells received 0.5 mM CaCl 2 and 10 mM LiCl. Total IPs were extracted with 20 mM formic acid, neutralized, and applied to an anion exchange column (Dowex AG 1-x8, Bio-Rad). Total IPs were then eluted by 2 M ammonium formate, 0.1 M formic acid and quantified by liquid scintillation counting. Calcium-stimulated IP production was expressed as the fold increase of [ 3 H]IPs accumulated in the stimulated cells compared with unstimulated cells.
cDNA Cloning and Sequencing-mRNA isolated from preconfluent keratinocytes cultured in KGM containing 0.07 or 1.2 mM Ca 2ϩ was reverse-transcribed into cDNA by reverse transcriptase (Superscript II, Life Technologies, Inc.), using a poly(T) primer (18) . Since the partial CaR cDNA clone (CaR 823) previously isolated from keratinocytes appeared to be identical to the parathyroid CaR, primers were designed to span the open reading frame of the published sequence of human parathyroid CaR. These primers included the 5Ј sense primers (5Ј-GAG AAA CTT CTG GGA GCC TC-3Ј, Ϫ70 -50 (exon 2), 5ЈnCaR; 5Ј-AAT CAA TTC AAG TCT TTC CTC CGA A-3Ј, 541-565 (exon 3), CaR541) and 3Ј antisense primers (5Ј-GCC CAG TCT CCT TCC AT-3Ј (exon 7), 3ЈnCaR-2; 5Ј-GGC TTG AAG AGA ATG ATG TA-3Ј, 2590 -2570 (exon 7), CaSeqprimerB). PCR amplification was performed using a proofreading enzyme, mixed Pwo DNA polymerase (Expand long template PCR system, Boehringer Mannheim) under optimized conditions. The expected size of the PCR product(s) for the CaR was 2-3 kb. PCR results were verified by Southern hybridization using a 32 P-labeled CaR cDNA clone which contains the sequence of the highly conserved transmembrane domain (CaR823). The appropriate PCR fragments were subcloned into a pCR II or pCR2.1 vector (Invitrogen). The colonies were screened with the CaR823 probe. The isolated cDNA clones were sequenced on both strands using vector-specific and gene-specific primers using a Dye termination cycle sequencing kit (ABI) on an Applied Biosystems 373A automated DNA sequencer. The DNA sequence was analyzed on the GCG DNA analysis package at the Computer Graphics Laboratory at the University of California, San Francisco.
Reconstruction of CaRs-The full-length CaR and the spliced variant lacking exon 5 were reconstructed by fusing two overlapping cDNAs, a 3Ј cDNA clone (CaR9 -12, 3.0 kb) and a 5Ј clone (CaR4 -101) in which exon 5 was deleted, using the PCR overlap extension method (19) . For the full-length CaR, the 5Ј AccI fragment of CaR4 -101 and 3Ј MscI fragment of CaR9 -12 were used as templates. For the spliced variant, the 3Ј SacI fragment of CaR9 -12 and the 5Ј SphI fragment of CaR4 -101 containing the deletion of exon 5 were used as templates (see Fig.  3 ). These fragment pairs were mixed and extended without primers for 5 cycles by Taq PLUS DNA polymerase (Stratagene). A primer set spanning the open reading frame (ORF) of CaR was designed. These primers were 5Ј-GAG AAA CTT CTG GGA GCC TC-3Ј (5ЈnCaR shown above) and 5Ј-GCC CAG TCT TCT CCT TCC AT-3 (3ЈnCaR-2). The full-length CaR and the spliced variant were prepared by 15 cycles of PCR. The resultant PCR products were subcloned into a mammalian expression vector, pCR3.1, which is derived from pcDNA3 using TA cloning (Invitrogen). The orientations of the desired CaRs in pCR3.1 were confirmed by restriction digestion. Sequences of reconstructed CaRs were confirmed by DNA sequencing using an Applied Biosystems 373A automated DNA sequencer. At least four independent clones were isolated and sequenced for each construct of full-length and spliced variant of CaR, respectively.
Transient Transfection of CaRs into HEK293 Cells-The CaRs were transiently transfected into HEK293 cells by the calcium phosphate method. The DNA for transfection was prepared using the Midi Plasmid purification kit (Qiagen). The HEK293 cells were maintained in Dulbecco's modified Eagle's medium (Life Technologies, Inc) with 10% fetal calf serum (Intergen). The DNA (5-10 g) was used to transfect cells in a T-75 flask or 100-mm culture dish. The DNA in 0.25 M CaCl 2 was added dropwise to equal volumes of 2ϫ HES (50 mM Hepes, 280 mM NaCl, 10 mM KCl, 1.5 mM Na 2 HPO 4 , 12 mM dextrose, pH 7.05-7.10). The cells were incubated with the DNA-calcium phosphate complex for 16 h. The expressed CaR protein was assayed 48 -72 h after the end of transfection.
Transient Transfection of Keratinocytes-The CaRs were transfected into cultured keratinocytes using Polybrene (20) . The cDNA construct of CaRs (10 g) and 50 g of Polybrene (hexadimethrin bromide, Aldrich) were added to preconfluent keratinocytes that were cultured with KGM containing 0.03 mM Ca 2ϩ in a 100-mm dish. The cells were incubated on the rocking shaker for 5-6 h at 37°C in 5% CO 2 . Then the medium was removed, and the cells were treated with 10% glycerol in KGM for 3 min. The cells were washed by PBS and maintained in KGM with 0.03 mM Ca 2ϩ . After 24 h, the cells were trypsinized and replated in a 6-well culture dish for assessment of calcium-stimulated IP production.
Immunostaining of CaR in Transfected HEK293 Cells-The expression of protein CaR in transiently transfected cells was detected by immunostaining (21) . The transfected cells on coverslips were fixed with Histochoice (Amresco, Solon, OH) for 15 min at room temperature. Endogenous peroxidases were then inhibited by incubating the cells in 0.6% H 2 O 2 in methanol for 30 min. The cells were then blocked with a blocking buffer (1% milk, 3% goat serum, 0.3% fish skin gelatin, and 0.01% Tween 20 in phosphate-buffered saline) for 1 h. Cells were then incubated 1 h at room temperature with an affinity purified polyclonal anti-CaR antibody (21) raised against an epitope containing amino acids 215-237 of bovine parathyroid CaR. This antibody was used at a dilution of 1:500. After washing the cells three times with blocking buffer, horseradish peroxidase-coupled goat anti-rabbit secondary antibody diluted 1:200 was added and incubated for 1 h at room termperature. The cells were then washed with blocking buffer three times and stained with the Fast DAB substrate system (Sigma) for 3 min. The color reaction was stopped by washing with water. The stained coverslips were mounted on slides with Permount (Fisher). Photomicrographs were taken with a ϫ 10 objective.
Membrane Protein Preparations from Transfected HEK293 CellsCrude plasma membranes were isolated from HEK293 cells transiently transfected with the human full-length or spliced variant CaR cDNAs as described (22) . Cultured cells in 100-mm culture plates were rinsed twice and scraped into PBS. Cells were pelleted, resuspended, and then sonicated in homogenization buffer (20 mM Tris-HCl, pH 7.4, containing 0.25 M sucrose, 4 mM MgCl 2 , 5 mM EGTA, and protease inhibitors including 2 g/ml of aprotinin, 1 g/ml of leupeptin, 20 g/ml of phenylmethylsulfonyl fluoride, 1 g/ml pepstatin). The homogenate was sedimented at 30,000 rpm for 30 min. The resultant pellet was extracted with RIPA buffer (50 mM Hepes, pH 7.4, 1% deoxycholate acid, 1% Triton X-100, 0.1% SDS, 150 mM NaCl, 1 mM EDTA, and protease inhibitors) for 30 min at 4°C. The soluble membrane protein fraction was separated from the insoluble cytoskeleton fraction by centrifugation at 30,000 rpm for 30 min. All steps were carried out at 4°C.
Digestion of Protein CaR with Peptide-N-glycosidase F (PNGase F) or with Endoglycosidase H (Endo H)-
The membrane protein fractions isolated from HEK293 cells transfected with cDNA of full-length CaR or its spliced variant were treated with or without PNGase F and Endo H as described (22) . Briefly, the 25 g of membrane protein was denatured and then incubated with or without 0.5 units of PNGase F (Boehringer Mannheim). The same amount of protein was separately incubated with or without of 2.5 units of Endo H (Boehringer Mannheim). Both digestions were carried out at 30°C overnight.
Western Analysis of Expressed CaR Protein-Protein concentration in the membrane protein preparations was determined using the Pierce BCA protein assay (Pierce). One hundred g of membrane protein samples prepared were electrophoresed on 6% polyacrylamide gels and electroblotted onto polyvinylidene difluoride membranes (0.2 m, BioRad). After blocking with 5% milk in TBST (10 mM Tris-Cl, pH 7.5, 150 mM NaCl, and 0.1% Tween 20), the blot was incubated with an affinity purified polyclonal antibody at a dilution of 1:500 (Affinity Bioreagents, Golden, CO) overnight at 4°C. As a control of specificity, the same samples were also incubated with the synthetic peptide of rat CaR (amino acids 12-27) against which the antibody was raised. Subsequently the samples were incubated with secondary antibody conjugated with horseradish peroxidase (anti-mouse Ig, sheep antibody, Amersham Pharmacia Biotech) for 1 h at room temperature. The bound antibody was visualized using an enhanced chemiluminescent system (ECL, Amersham Pharmacia Biotech).
Northern Hybridization-Poly(A) RNA was isolated from keratinocytes, electrophoresed (8) , and hybridized (Ambion) with a 32 P-labeled RNA probe of CaR. A 323-bp DNA fragment corresponding to human CaR-1472-1928 was amplified by PCR from the cDNA clone of CaR9 -12 using a primer set of sense (5Ј-TCA TCA ACT GGC ACC TCT CC 3Ј, 1472-91, INTprimer2) and antisense primer (5Ј-CAA TGA TCC CTT TCC TGG TC-3Ј, 1647-1666, CaRexon5). This fragment was subcloned into pCRII by TA cloning (Invitrogen). The cloned DNA was linearized, and the antisense RNA probe was synthesized. The membranes were washed under stringent conditions (0.1ϫ SSPE, 65°C). An equivalent blot was probed with a 32 P-labeled cDNA probe for G3PDH (CLONTECH) as a control to estimate RNA loading. The message size was estimated from the comparison of the mobility of molecular weight markers (RNA ladder, 0.24 -9.5 kb, Life Technologies, Inc.).
RNase Protection Assay-The antisense RNA probe was designed to encompass the junction between exons 4 and 5. It was transcribed from the PCR product of CaR with a T7 promotor sequence on the 3Ј end. The 299-bp DNA fragment was amplified by PCR using sense primer (from exon 4, 5Ј-CCC CTT ACA TAG ATT ACA CGC-3Ј, 1217-1237, hCaR1217F) and antisense primer (from exon 5, 5Ј-TAA TAC GAC TCA CTA TAG GGA GGG GAG AGG TGC CAG TTG ATG A-3Ј, 1491-1471 ϩ T7 promotor, hCaR1491RT7). The antisense RNA probe was transcribed using MAXIscript (Ambion) from 10 ng of the PCR fragment using [ 32 P]UTP. The RNA probe was purified by gel electrophoresis and hybridized with total RNA from keratinocytes. The probe was digested with RNase A ϩ T 1 and analyzed on polyacrylamide gels as described (23) . The size of the protected RNA bands was estimated by RNA molecular weight markers (RNA century marker, Ambion). The total RNA from normal human kidney used as control was from CLONTECH.
RT-PCR Analysis of CaR Transcripts-The expression of the two forms of CaR also was determined by RT-PCR using a set of primers that spanned the missing region (exon 5) of the spliced variant. Total RNA was isolated from cultured keratinocytes at various stages of differentiation or from normal neonatal foreskin epidermis. The total cDNA pool was prepared by reverse transcription as described above. The sense primer from the 4th exon (5Ј-AGG AAG TCT GTC CAC AAT GG-3Ј, 1018 -1038, CAR1018) and the antisense primer from the 6th exon (5Ј-CAA TGA TCC CTT TCC TGG TC-3Ј, 1646 -1666, CAR exon 5) were used. Each cDNA also was amplified using a pair of primers for human G3PDH (CLONTECH) as a control for cDNA loading in the PCR assay. Amplification was carried out using Taq polymerase PLUS (Stratagene) for 30 cycles for CaR and 25 cycles for G3PDH. The PCR products were analyzed on a 3% agarose gel electrophoresis. Molecular weights of the bands were estimated by X174/HaeIII fragments (Life Technologies, Inc.) as standards. PCR was done twice, and the PCR results were confirmed by Southern analysis using 32 P-labeled CaR cDNA (CaR9 -12) as a probe. (Fig. 3) . As this variant has an in frame deletion, it would be translated into a receptor missing 77 amino acids (460 -536) (Fig. 4) . Besides the spliced variant, two partial cDNA clones derived from full-length CaR message also were cloned. The 3Ј cDNA clone (CaR9 -12) is a 2.7-kb cDNA fragment (541-3277), and the 5Ј clone (CaRI) is a 0.6-kb fragment (Ϫ70 -589) containing the translational initiation site (Fig. 3) . These two clones encompassed the ORF of the CaR. Our keratinocyte CaR sequence differs from the reported parathyroid CaR sequence (11) in one nucleotide that caused an amino acid change at residue 986 (Ala 3 Ser). The same residue was recently reported as a benign polymorphism observed in 30% of the normal population (26) . [Ca 2ϩ ] o -The functions of the two forms of CaR, full-length and its alternatively spliced variant, were compared by transfection of the cloned cDNAs of the two CaRs into HEK293 cells (human embryonic kidney cells). These cells do not have endogenous CaR. The cDNAs encoding complete ORFs of the full-length and the spliced variant were reconstructed by overlap extension PCR and subcloned into the mammalian expression vector pCR3.1 as described under "Experimental Procedures." The same amount of cDNA for both forms of CaR was then transiently transfected into HEK293 cells, and calcium-stimulated IP production was compared. Four independent clones for each form were isolated and assayed. All of the clones (RE-3, -4, -6, and -8) of the full-length CaR had a 5-10-fold increase in IP production in response to 5.0 mM Ca 2ϩ stimulation (Fig. 5A) . In contrast, none of the clones (SE-3, -6, -7, and -10) of the spliced variant showed a significant increase in IP production when compared with HEK293 cells transfected by vector DNA alone (Fig. 5A ) even when the calcium was raised to 40 mM (Fig. 5B) .
RESULTS

The
The Spliced Variant of CaR Fails to Signal the IP Response to
The cDNA of both forms of CaR were then transfected into keratinocytes. The full-length CaR (RE-3) increased IP production in response to calcium, whereas the spliced variant (SE-3) did not show a significant increase compared with the vector control (Fig. 5C ). The calcium-induced increase in IP production in the vector control is likely to represent calcium-stimulated IP production mediated by the endogenous CaR present in keratinocytes. To ensure that observed differences in the IP responses were not due to differences in expression, we immunostained the same transfected cells with an antibody raised against bovine CaR which reacts with human CaR. The expression of CaR protein was detected in 10 -20% of the HEK293 cells transfected with either full-length CaR (RE-3) (Fig. 6B) or alternatively spliced CaR (SE-3) (Fig. 6C) . Different clones produced comparable results. No staining was observed in control HEK293 cells transfected by vector DNA (Fig. 6A) .
The Spliced Variant Reduced the IP Response of Full-length CaR-To determine whether the spliced variant interfered with the function of full-length CaR, the spliced variant was coexpressed with full-length CaR, and calcium-stimulated IP production was measured in HEK293 cells. When the spliced variant (SE) was expressed with the full-length CaR (RE) at the ratio of 9:1, the IP production was reduced by 33% (Fig. 5D) .
Both Full-length CaR and Its Spliced Variant Are in the Membrane-Membrane proteins were isolated from HEK293 cells transiently transfected with cDNAs of full-length or spliced variant CaR and were analyzed by Western blotting. The cells transfected with the full-length CaR cDNA (Fig. 7A,  lane 2, RE-3, and lane 3, RE-8 ) expressed multiple immunoreactive bands. The two major bands, estimated as ϳ140 and ϳ160 kDa, correspond to the major glycosylated forms of bovine CaR expressed in stably transfected HEK293 cells (Fig.  7A, lane 6) (22) . In addition, a minor band of ϳ120 kDa, which is thought to represent the non-glycosylated form of CaR (22), was observed on longer exposed film (Fig. 8, lane 2) . In contrast, the alternatively spliced form of CaR (Fig. 7A, lane 4 , SE-3 and lane 5, SE-10) generated a single dominant band of ϳ130 kDa and a minor ϳ110-kDa band (Fig. 8, lane 4) . No immunoreactive band was observed when the same blot was incubated with the same antibody preabsorbed with the specific peptide against which it was raised (Fig. 7B, lanes 1-6) .
Different Glycosylation Patterns of Full-length CaR and Its Alternatively Spliced Form-To characterize further the multiple forms of the CaR expressed in HEK293 cells, we tested the sensitivity of the CaR proteins to endoglycosidases. The ϳ140-and ϳ160-kDa bands of the full-length CaR were converted to an ϳ120-kDa band by PNGase F treatment, which hydrolyzes all N-linked carbohydrate chains (Fig. 8, lane 1 and 2) , whereas the ϳ130-kDa band of the spliced variant was digested to an ϳ110-kDa band (Fig. 8, lane 3 and 4) . The ϳ120-and ϳ110- kDa bands should represent the non-glycosylated CaR of fulllength and spliced variant, respectively, because the same bands were observed in tunicamycin-treated cells (data not shown). In contrast to the ϳ140-kDa band of full-length CaR, the ϳ160-kDa band was only sensitive to PNGase F but not Endo H (Fig. 8, lane 5 and 6) , which cleaves high mannose type oligosaccharide chains. However, the spliced variant band, ϳ130 kDa, was converted to an ϳ110-kDa band by the same Endo H treatment (Fig. 8, lane 7 and 8) . These results indicate that the full-length CaR and its spliced variant have different N-linked glycosylation. The spliced variant has only high mannose type oligosaccharide chains on the expressed protein, whereas the full-length CaR has two different N-glycosylated proteins (22) . The deletion of two glycosylation sites on Asn-468 and Asn-488 on exon 5 may be responsible for the change of glycosylation pattern in the spliced variant of CaR.
Expression of the CaR Transcripts during Keratinocyte Differentiation-We next examined the expression of CaRs during keratinocyte differentiation. Northern hybridization using a 32 P-labeled CaR RNA probe showed the CaR transcripts of 4.5 and 2.0 kb in undifferentiated keratinocytes (Fig. 9A, lane 1) . The level of the 4.5-kb transcript was decreased in the fully differentiated keratinocytes (Fig. 9A, lane 2) . The antisense RNA probe was prepared to encompass the junction of exons 4 and 5 for the RNase protection assay. The protected fragment derived from the full-length CaR (274 nucleotides) was observed in the undifferentiated cells (Fig. 9B, lane 2) , and it decreased in the differentiated cells (lane 3). The faint 161-nucleotide band representing the spliced variant lacking exon 5 (Fig. 9B, lane 2) was detected in the undifferentiated keratinocytes (lane 2) and did not appear to decrease to the same extent as the 274-nucleotide band. The kidney also showed the same two bands (lane 1) indicating that the same spliced variant occurs in the kidney. Equivalent amounts of G3PDH were FIG. 5 . A, calcium-stimulated IP production in HEK293 cells transfected with the CaR cDNAs. cDNAs containing the complete ORF of full-length CaR and its spliced variant were reconstructed by overlap extension PCR. Four independent clones were isolated and assayed for each form. The cDNAs containing full-length CaR (clones RE-3, 4, 6, and 8) or spliced variant (clones SE-3, 6, 7, and 10) were transiently transfected into HEK293 cells and assayed for the IP response to 5 mM CaCl 2 . Calcium-stimulated IP production was expressed as the fold increase of IP accumulation in the stimulated cells compared with unstimulated cells. Each data point is the mean Ϯ S.D. (n ϭ 3). The full-length CaR mediated a significant increase in IP production unlike the vector only (n ϭ 3, p Ͻ 0.001) or the spliced variant (n ϭ 3, p Ͼ 0.03). B, dose-response curve of IP production to calcium stimulation in HEK293 cells transfected with the full-length CaR (RE-3) (closed circles) or spliced variant (SE-3) (open circles) of CaR cDNA. Transfected HEK293 cells were stimulated with various concentrations of Ca 2ϩ up to 40 mM, and the fold increase in IP production was calculated based on the unstimulated controls. Each data point shows the mean Ϯ S.D. (n ϭ 3). C, overexpression of CaR potentiated the calcium-stimulated IP production in keratinocytes. The same cDNAs containing full-length CaR (clones RE-3) and spliced variant (clones SE-3) were transfected into undifferentiated keratinocytes cultured in 0.03 mM calcium. 48th after transfection, the IP response to calcium was assayed as described in B. The fold increase of total IP production stimulated by 10 mM CaCl 2 was compared with the cells treated with 0.03 mM CaCl 2 . Each data point is the mean Ϯ S.D. (n ϭ 3). The full-length CaR mediated a greater increase (p Ͻ 0.03) in IP production than the spliced variant which was not significantly different from the vector control (p Ͼ 0.03). The increase observed in the vector control is likely to represent the IP response mediated by the endogenous CaR in keratinocytes. D, coexpression of the spliced variant with the full-length CaR. The cDNA construct of the spliced variant (SE-3) was transiently cotransfected with the full-length CaR cDNA (RE-3) into HEK293 cells, and calcium-stimulated IP production was measured. Different amounts of cDNA of the spliced variant were added with constant amounts of full-length CaR cDNA (2 g). When the molecular ratio of spliced variant to full-length CaR was 9:1, the function of full-length CaR was partially reduced. The total amount of cDNA added in the each transfection was held constant at 20 g by adding vector DNA to eliminate the nonspecific effects caused by increasing amounts of cDNA. expressed in both undifferentiated and differentiated samples (data not shown). The full-length and spliced variant of the CaR were also detected by RT-PCR using a primer set encompassing exon 5. In the experiment shown in Fig. 9C , the 650-bp full-length CaR was expressed maximally in the least differentiated keratinocytes (lane 1, cultured in 0.03 mM Ca 2ϩ for 5 days, or lane 2 , in 0.1 mM Ca 2ϩ for 5 days) and decreased as the cells differentiated (lanes 3-12) with time under the influence of calcium. In contrast, the expression of the 420-bp band of the spliced variant remained relatively constant as the keratinocytes differentiated (lanes 2-12) . The intermediate band was found to be a heterodimer between the 650-and 420-bp fragments. The ratio of full-length CaR to spliced variant decreased during differentiation as shown in the lower panel of Fig. 9C . The Southern hybridization of PCR bands using a 32 P-labeled cDNA probe (CaR9 -12) and DNA sequence analysis confirmed that the amplified PCR bands were CaR transcripts (data not shown). The level of G3PDH transcripts showed no significant differences among the samples (data not shown). These results showed that these two forms of CaR are differentially expressed during keratinocyte differentiation.
DISCUSSION
Extracellular calcium ([Ca 2ϩ ] o ) is a major regulator of keratinocyte growth and differentiation (4) . Undifferentiated keratinocytes respond rapidly to an increase in [Ca 2ϩ ] o with an increase of [Ca 2ϩ ] i and IP 3 production as shown by our data. These data suggest the presence of a membrane receptor that mediates the [Ca 2ϩ ] o signal and initiates calcium-induced differentiation. We obtained a partial sequence (14) for the receptor identical to the CaR found in the parathyroid gland (10, 11) . During our efforts to clone and sequence the full-length keratinocyte CaR, we found an alternatively spliced form of the CaR lacking exon 5. The deletion of exon 5 abolished the function of the CaR with respect to calcium-stimulated IP production. The two forms of CaR were differentially expressed during keratinocyte differentiation. The transcript of the functionally active full-length CaR was maximal in undifferentiated keratinocytes and decreased as the cells differentiated. These changes corre- The digested proteins were detected by Western analysis using a polyclonal anti-bovine CaR antibody (21) raised against the peptide 915-935 of bovine CaR which cross-reacts with human CaR. The two bands of full-length CaR (cDNA clone, RE-3), ϳ160 and ϳ140 kDa (lane 2), were digested to the ϳ120-kDa band (lane 1) by PNGase F treatment, and the ϳ130-kDa band (lane 4) of the spliced variant CaR (cDNA clone, SE-3) was digested to an ϳ110-kDa band (lane 3). In contrast, Endo H digested the ϳ140-kDa band of the full-length CaR and the ϳ130-kDa band of the spliced variant but not the ϳ160-kDa band of the full-length CaR. Only weaker bands were observed after Endo H treatment (lanes 5 and 7) because only part of the samples were loaded on this particular gel. When we loaded equivalent amounts of the samples, comparable amounts of the digested bands were observed (data not shown).
lated with the decrease in the ability of [Ca 2ϩ ] o to stimulate [Ca 2ϩ ] i and IP production in these cells. However, the CaRs changed earlier than the decreased response of [Ca 2ϩ ] i stimulated by [Ca 2ϩ ] o during keratinocyte differentiation perhaps because the change in mRNA level preceded the change in protein level.
The lack of exon 5 results in the loss of 77 amino acids in the putative extracellular calcium sensing domain, a region containing 10 acidic amino acids and 2 glycosylation sites (see Fig.  4 ). The deleted region does not contain amino acids previously reported to be mutated in familial hypercalcemia hypocalciuria or autosomal dominant hypocalcemia (12) .
Several possibilities for the failure of the alternatively spliced CaR to mediate calcium-stimulated IP production were considered as follows: 1) a change in binding affinity to calcium because of the deletion of 10 acidic amino acids that might be involved in cation binding; 2) failure to produce a protein capable of being transferred to the cell-surface membrane because of a change in glycosylation; 3) failure to couple the CaR to a G-protein to transfer the signal initiated by calcium binding.
A change in binding affinity to calcium is possible. However the deletion of exon 5 completely abolished the response to calcium up to 40 mM, suggesting that a subtle change in affinity for calcium does not explain the lack of response. Changes in glycosylation may be important for the function of the CaR. The glycosylation pattern of the CaR appears to be altered in some forms of familial hypercalcemia hypocalciuria (22) . Tunicamycin treatment of transfected HEK293 cells expressing the CaR abolished the IP response to extracellular calcium (27) . A truncated CaR having a single Endo H-sensitive glycosylated CaR did not respond to [Ca 2ϩ ] o to produce IP, and it was not expressed on the cell surface (28) . The spliced variant produced a single Endo H-sensitive N-glycosylated protein of ϳ130 kDa in transfected HEK293 cells unlike the two glycosylated bands, ϳ140 and ϳ160 kDa produced by the full-length CaR. Only the ϳ140-kDa band of the full-length CaR was Endo H-sensitive. However, the spliced variant when expressed in these cells does get inserted into the membrane. Conceivably, coupling of a G-protein to the receptor might be affected by deletion of the region encoded by exon 5. Our analysis of the secondary structure of CaR indicates that exon 5 encodes a highly flexible and hydrophilic domain containing three small ␤ sheets that may bands were analyzed by urea/4% polyacrylamide gel electrophoresis. The expected 274-nucleotide protected fragment derived from the fulllength CaR was detected in the undifferentiated cells (lane 2) but decreased in the differentiated cells (lane 3) compared with tRNA control (lane 4). The less intense 161-nucleotide band representing the spliced variant lacking exon 5 (lane 2) was also found in the undifferentiated keratinocytes and appeared to be less diminished in the differentiated cells (lane 3). The kidney also showed the same 274-and 161-nucleotide bands (lane 1). Lane P contained undigested probe, and lane 4 showed the tRNA control. The size of RNA was estimated by the mobility of the in vitro transcribed RNA molecular weight markers (lane M). C, RT-PCR analysis of the alternatively spliced form of CaR in human keratinocytes. Full-length and spliced variant CaRs were recognized as PCR products with different sizes. Human keratinocytes were grown in 0.07 mM Ca 2ϩ until 70% confluent and then switched to 0.03, 0.1, or 1.2 mM Ca 2ϩ . RNA was isolated at different time points after the calcium switch (5, 7, 14, and 21 days). RNA from each sample was reverse-transcribed and amplified by PCR using a primer set spanning exon 5. The two amplified DNA bands are shown by an arrow. The upper band was consistent with the M r of full-length (650 bp) CaR. The lower band was consistent with the alternatively spliced form (420 bp). The middle band is a heterodimer of the 650 and 420 bands as shown by subcloning and DNA sequencing of this band. The PCR bands were scanned by densitometry, and the ratio of full-length to spliced variant was calculated as shown in the lower panel. Two independent PCR analyses showed the same results.
FIG. 9.
A, Northern analysis of CaR in human keratinocytes. Poly(A) RNA (3 g) from keratinocytes was electrophoresed, transblotted, and probed with a 32 P-labeled antisense RNA probe (323 bp) as described under "Experimental Procedures." A 4.5-kb message was detected in undifferentiated preconfluent keratinocytes cultured with 0.03 mM calcium (lane 1), and it decreased in fully differentiated cells cultured with 1.2 mM calcium (10 days postconfluent) (lane 2). A 2.0-kb transcript was also detected in both stages of differentiation. A control probe (G3PDH) was used to normalize the amount of RNA as shown in the bottom of the blot. The membrane was washed under stringent conditions (0.1ϫ SSPE, 65°C). B, RNase protection assay analysis of CaR transcripts in human keratinocytes. The antisense RNA probe was designed to encompass the junction between exons 4 and 5 to distinguish the two forms of CaR. The 32 P-labeled RNA probe was hybridized to total RNA of keratinocytes from the same two stages of differentiation as described in A. The samples were digested by RNase, and the protected be essential for the proper transmission of the external signal to the intracellular domains.
Other alternatively spliced forms of CaR have been reported. One variant cloned from a human kidney library has a deletion of both exons 5 and 6 resulting in a frameshift and the generation of an early stop codon. This would be unlikely to result in a functional receptor (29) . A variant reported from human parathyroid gland has a 10-amino acid insertion after exon 5 and displayed the same receptor activity as full-length CaR (11). It is not clear how abundant either of these forms are in any tissue, and these forms were different from the variant identified in keratinocytes.
In the current studies, we provide evidence to show that the ratio of two forms of CaR change with keratinocyte differentiation. The functionally active full-length CaR is expressed in undifferentiated keratinocytes and decreases as keratinocytes differentiate. The alternatively spliced variant is expressed throughout differentiation, and as the full-length CaR declines, the spliced form may further reduce calcium responsiveness by a dominant negative effect. These changes in the CaR with differentiation coincide with and may be responsible for the loss of calcium responsiveness in terms of [Ca 2ϩ ] i and IP stimulation as keratinocytes differentiate.
